Search research articles
Contact Us
Filters
Showing results (121-130 of 166) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancer
Christopher J Sweeney, Chris H Takimoto, Jane E Latz, et al.
Kidney International
|
June 17, 2026
Genome-wide Screen Identifies Peroxisomal Role in APOL1 Podocytopathy
Jiyoung Kim, Isaac Z Karel, Huijuan Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Pharmacokinetics and toxicity of weekly docetaxel in older patients
Arti Hurria, Mark T Fleming, Sharyn D Baker, et al.
Breast Cancer Research and Treatment
|
February 26, 2011
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer
Roisin M Connolly, Michelle A Rudek, Elizabeth Garrett-Mayer, et al.
Cancer Research
|
February 18, 2017
OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues
Christina D Drenberg, Alice A Gibson, Stanley B Pounds, et al.
Pediatric Blood & Cancer
|
April 15, 2017
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03)
Todd M Cooper, Edward Allan Racela Sison, Sharyn D Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2008
Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer
Dana Rathkopf, Michael A Carducci, Michael J Morris, et al.
Investigational New Drugs
|
May 19, 2019
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML
Jae Yoon Jeon, Qiuhong Zhao, Daelynn R Buelow, et al.
The Journal of Clinical Investigation
|
December 12, 2017
Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia
Jolieke G van Oosterwijk, Daelynn R Buelow, Christina D Drenberg, et al.
Pharmacogenomics
|
April 1, 2011
Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes
Jatinder K Lamba, Kristine R Crews, Stanley B Pounds, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 166) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancer
Christopher J Sweeney, Chris H Takimoto, Jane E Latz, et al.
Kidney International
|
June 17, 2026
Genome-wide Screen Identifies Peroxisomal Role in APOL1 Podocytopathy
Jiyoung Kim, Isaac Z Karel, Huijuan Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Pharmacokinetics and toxicity of weekly docetaxel in older patients
Arti Hurria, Mark T Fleming, Sharyn D Baker, et al.
Breast Cancer Research and Treatment
|
February 26, 2011
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer
Roisin M Connolly, Michelle A Rudek, Elizabeth Garrett-Mayer, et al.
Cancer Research
|
February 18, 2017
OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues
Christina D Drenberg, Alice A Gibson, Stanley B Pounds, et al.
Pediatric Blood & Cancer
|
April 15, 2017
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03)
Todd M Cooper, Edward Allan Racela Sison, Sharyn D Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2008
Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer
Dana Rathkopf, Michael A Carducci, Michael J Morris, et al.
Investigational New Drugs
|
May 19, 2019
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML
Jae Yoon Jeon, Qiuhong Zhao, Daelynn R Buelow, et al.
The Journal of Clinical Investigation
|
December 12, 2017
Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia
Jolieke G van Oosterwijk, Daelynn R Buelow, Christina D Drenberg, et al.
Pharmacogenomics
|
April 1, 2011
Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes
Jatinder K Lamba, Kristine R Crews, Stanley B Pounds, et al.
Page
of 17